Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Artículo en Inglés | MEDLINE | ID: mdl-31550212

RESUMEN

Some of the chemicals in materials used for packaging food may leak into the food, resulting in human exposure. These include so-called Non-intentionally Added Substances (NIAS), many of them being unidentified and toxicologically uncharacterized. This raises the question of how to address their safety. An approach consisting of identification and toxicologically testing all of them appears neither feasible nor necessary. Instead, it has been proposed to use the threshold of toxicological concern (TTC) Cramer class III to prioritise unknown NIAS on which further safety investigations should focus. Use of the Cramer class III TTC for this purpose would be appropriate if amongst others sufficient evidence were available that the unknown chemicals were not acetylcholinesterase inhibitors or direct DNA-reactive mutagens. While knowledge of the material and analytical chemistry may efficiently address the first concern, the second could not be addressed in this way. An alternative would be use of a bioassay capable of detecting DNA-reactive mutagens at very low levels. No fully satisfactory bioassay was identified. The Ames test appeared the most suitable since it specifically detects DNA-reactive mutagens and the limit of biological detection of highly potent genotoxic carcinogens is low. It is proposed that for a specific migrate, the evidence for absence of mutagenicity based on the Ames test, together with analytical chemistry and information on packaging manufacture could allow application of the Cramer class III TTC to prioritise unknown NIAS. Recommendations, as well as research proposals, have been developed on sample preparation and bioassay improvement with the ultimate aim of improving limits of biological detection of mutagens. Although research is still necessary, the proposed approach should bring significant benefits over the current practices used for safety evaluation of food contact materials.


Asunto(s)
Bioensayo , Análisis de los Alimentos , Contaminación de Alimentos/análisis , Embalaje de Alimentos , Humanos
2.
Basic Clin Pharmacol Toxicol ; 115(1): 18-23, 2014 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-24461077

RESUMEN

High-content imaging/analysis has emerged as a powerful tool for predictive toxicology as it can be used for identifying and mitigating potential safety risks during drug discovery. By careful selection of end-points, some cellular assays can show better predictivity than routine animal toxicity testing for certain adverse events. Here, we present the perhaps most utilized high-content screening assays for predictive toxicology in the pharmaceutical industry. Multi-parametric imaging of cell health in simple and cost-effective model systems can be used to predict human hepatotoxicity and elucidate mechanisms of toxicity, and imaging of bile salt transport inhibition in sandwich-cultured hepatocytes can be used to predict cholestasis-inducing compounds. Imaging of micronuclei formation in simple cell models can be used to detect genotoxic potential and elucidate anuegenic or clastogenic mode of actions. The hope is that application of these relatively predictive assays during drug discovery will reduce toxicity and safety-related attrition of drug development programmes at later stages.


Asunto(s)
Enfermedad Hepática Inducida por Sustancias y Drogas/diagnóstico , Daño del ADN/efectos de los fármacos , Hígado/efectos de los fármacos , Pruebas de Toxicidad/métodos , Animales , Ácidos y Sales Biliares/antagonistas & inhibidores , Ácidos y Sales Biliares/metabolismo , Colestasis/diagnóstico , Análisis Costo-Beneficio , Hepatocitos/efectos de los fármacos , Humanos , Hígado/metabolismo
3.
Cell Rep ; 5(4): 952-60, 2013 Nov 27.
Artículo en Inglés | MEDLINE | ID: mdl-24239353

RESUMEN

Expression of the human Parkinson-disease-associated protein α-synuclein in all Drosophila neurons induces progressive locomotor deficits. Here, we identify a group of 15 dopaminergic neurons per hemisphere in the anterior medial region of the brain whose disruption correlates with climbing impairments in this model. These neurons selectively innervate the horizontal ß and ß' lobes of the mushroom bodies, and their connections to the Kenyon cells are markedly reduced when they express α-synuclein. Using selective mushroom body drivers, we show that blocking or overstimulating neuronal activity in the ß' lobe, but not the ß or γ lobes, significantly inhibits negative geotaxis behavior. This suggests that modulation of the mushroom body ß' lobes by this dopaminergic pathway is specifically required for an efficient control of startle-induced locomotion in flies.


Asunto(s)
Modelos Animales de Enfermedad , Dopamina/metabolismo , Neuronas Dopaminérgicas/metabolismo , Drosophila melanogaster/metabolismo , Locomoción/fisiología , Enfermedad de Parkinson/metabolismo , Animales , Animales Modificados Genéticamente , Encéfalo/metabolismo , Proteínas de Drosophila/metabolismo , Femenino , Proteínas Fluorescentes Verdes/genética , Humanos , Canales Iónicos , Locomoción/genética , Cuerpos Pedunculados/inervación , Estrés Oxidativo , Enfermedad de Parkinson/fisiopatología , Reflejo de Sobresalto/genética , Reflejo de Sobresalto/fisiología , Transducción de Señal , Canal Catiónico TRPA1 , Canales Catiónicos TRPC/metabolismo , alfa-Sinucleína/biosíntesis , alfa-Sinucleína/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA